Topical application of imatinib mesylate suppresses vitamin D3 analog-induced dermatitis in Balb/c mice.
Harutaka SeshimoChizu EgusaTatsuo MaedaTakafumi NumataYukari OkuboKazutoshi HaradaTomonobu ItoPublished in: Experimental dermatology (2022)
IMT reduced the skin symptoms in a MC903-induced, murine AD model, suggesting that it may have potential as a new treatment for AD.